Perspective Therapeutics Inc. buy BiotechBee
Start price
08.09.24
/
60%
€14.20
Target price
31.07.27
€20.00
Performance (%)
-76.20%
End price
14.12.24
€3.38
Summary
This prediction ended on 14.12.24 with a price of €3.38. The BUY prediction by BiotechBee for Perspective Therapeutics Inc. performed very badly with a performance of -76.20%. BiotechBee has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Perspective Therapeutics Inc. | - | - | - |
| iShares Core DAX® | 0.794% | 2.841% | 22.630% |
| iShares Nasdaq 100 | 0.016% | -0.939% | 6.943% |
| iShares Nikkei 225® | 0.309% | -0.648% | 13.619% |
| iShares S&P 500 | 0.181% | -0.442% | 4.692% |
According to BiotechBee what are the pros and cons of Perspective Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Perspective Therapeutics Inc. diskutieren
Buy mit Kursziel 20,0
In the thread Trading Perspective Therapeutics Inc.
Buy beendet

